Literature DB >> 11435271

Antipsychotic medication and venous thrombosis.

R Thomassen1, J P Vandenbroucke, F R Rosendaal.   

Abstract

BACKGROUND: In an autopsy series, 10 out of 27 deaths in which 'idiopathic' pulmonary emboli were discerned as the sole cause of death had occurred in psychiatric patients. AIMS: To investigate whether antipsychotic medication is a risk factor for venous thrombosis.
METHOD: A description of the 10 psychiatric patients was obtained from the pulmonary emboli autopsy reports. We carried out a brief historic overview of the literature. We re-analysed data from the Leiden Thrombophilia Study (LETS), a case-control study on patients with venous thrombosis.
RESULTS: In the autopsy reports, five out of 10 psychiatric patients with fatal pulmonary embolism had confirmed use of antipsychotic drugs. After the application of chlorpromazine and its analogues a higher incidence of venous thrombosis in psychiatric patients was described in the German literature between 1953 and 1977. In the re-analysis of the LETS case-control study, four patients used antipsychotic drugs versus none in the control group. Recent epidemiological studies of good methodological quality have confirmed these findings.
CONCLUSIONS: Venous thrombosis appears to be associated with the use of antipsychotic drugs in psychiatric patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435271     DOI: 10.1192/bjp.179.1.63

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  17 in total

Review 1.  Antipsychotic-induced venous thromboembolism: a review of the evidence.

Authors:  Staffan Hägg; Olav Spigset
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies.

Authors:  Corrado Barbui; Valentino Conti; Andrea Cipriani
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

Review 3.  Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Authors:  Anna K Jönsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

4.  Muddy clinical waters: a missed pulmonary embolus.

Authors:  Nathaniel Lee; Simon Rupert Bax
Journal:  BMJ Case Rep       Date:  2014-03-12

5.  Idiopathic pulmonary thromboembolism in the course of intensive psychiatric inpatient care: case report and treatment guidelines.

Authors:  Shane J McInerney; Colm McDonald
Journal:  BMJ Case Rep       Date:  2012-09-07

6.  Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions.

Authors:  Staffan Hägg; Andrew Bate; Malin Stahl; Olav Spigset
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

7.  Deep venous thrombosis and atypical antipsychotics: three cases report.

Authors:  Fatemeh Sheikhmoonesi; Seyyedeh Fatemeh Bahari Saravi
Journal:  Daru       Date:  2012-10-31       Impact factor: 3.117

8.  Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers.

Authors:  Masamichi Ishioka; Norio Yasui-Furukori; Norio Sugawara; Hanako Furukori; Shuhei Kudo; Kazuhiko Nakamura
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-24       Impact factor: 2.570

9.  Atypical antipsychotic use is an independent predictor for the increased mean platelet volume in patients with schizophrenia: A preliminary study.

Authors:  Murat Semiz; Hasan Yücel; Onder Kavakçı; Osman Yıldırım; Ali Zorlu; Mehmet Birhan Yılmaz; Zekeriya Küçükdurmaz; Fatih Canan
Journal:  J Res Med Sci       Date:  2013-07       Impact factor: 1.852

10.  Antidepressants, Depression, and Venous Thromboembolism Risk: Large Prospective Study of UK Women.

Authors:  Lianne Parkin; Angela Balkwill; Siân Sweetland; Gillian K Reeves; Jane Green; Valerie Beral
Journal:  J Am Heart Assoc       Date:  2017-05-17       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.